AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9560175 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed exposure practice
Number of subjects: 74
Study 7889814 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% nitrous oxide in oxygen
Number of subjects: 0
Study 7889814 — intervention group
Group type: COMPARATOR
Intervention: 100% oxygen (placebo)
Number of subjects: 0
Study 3279757 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g amoxycillin suspension twice a day for 8 days
Number of subjects: 45
Study 3279757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 3279757 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin single blind for 14 days (in second study phase)
Number of subjects: 45
Study 30195124 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 246
Study 30195124 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk Walking
Number of subjects: 246
Study 30195124 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 246
Study 27058680 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with human pain assessment (T+)
Number of subjects: 0
Study 27058680 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with automated pain assessment (T)
Number of subjects: 0
Study 27058680 — intervention group
Group type: COMPARATOR
Intervention: No training with automated pain assessment (C)
Number of subjects: 0
Study 24828327 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9% saline
Number of subjects: 42
Study 24828327 — intervention group
Group type: COMPARATOR
Intervention: Colloid solution (gelatin, hydroxyethyl starch 200/0.5 or albumin)
Number of subjects: 42
Study 22674493 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation (PTNS)
Number of subjects: 50
Study 21620376 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated checking of a virtual stovetop with novel stimuli (color changed every five trials)
Number of subjects: 65
Study 21620376 — intervention group
Group type: COMPARATOR
Intervention: Repeated checking of a virtual stovetop (standard stimulus)
Number of subjects: 65
Study 21620376 — intervention group
Group type: COMPARATOR
Intervention: Repeated checking of a different stimulus (not specified)
Number of subjects: 65
Study 19366459 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 774
Study 19366459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 774
Study 16450662 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg ZOL every two weeks
Number of subjects: 60
Study 16450662 — intervention group
Group type: COMPARATOR
Intervention: 4 mg ZOL every four weeks
Number of subjects: 60
Study 15293159 — intervention group
Group type: COMPARATOR
Intervention: Tissucol (Group A)
Number of subjects: 20
Study 15293159 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fibrin glue (Group B)
Number of subjects: 20
Study 15293159 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 11368195 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-session behavioral intervention introducing female-initiated methods of HIV prevention
Number of subjects: 35
Study 11368195 — intervention group
Group type: COMPARATOR
Intervention: HIV education control
Number of subjects: 35
Study 7480054 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression treatment
Number of subjects: 0
Study 2333541 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedicated with intramuscular atropine 0.015 mg/kg
Number of subjects: 80
Study 2333541 — intervention group
Group type: COMPARATOR
Intervention: Non-premedicated patients
Number of subjects: 80
Study 356683 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunisolide nasal spray (150 microgram/day)
Number of subjects: 48
Study 356683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 31483941 — intervention group
Group type: EXPERIMENTAL
Intervention: LED‐RL at fluences of 160-640 J/cm2 (STARS 1)
Number of subjects: 115
Study 31483941 — intervention group
Group type: EXPERIMENTAL
Intervention: LED‐RL at fluences of 480-640 J/cm2 (STARS 2)
Number of subjects: 115
Study 31483941 — intervention group
Group type: COMPARATOR
Intervention: Mock irradiation
Number of subjects: 115
Study 30671945 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 0
Study 30671945 — intervention group
Group type: COMPARATOR
Intervention: Standard NICU care
Number of subjects: 0
Study 28418937 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist Continuous Noninvasive Arterial Pressure Monitoring (CNAP)
Number of subjects: 60
Study 28418937 — intervention group
Group type: COMPARATOR
Intervention: Invasive Arterial Pressure Monitoring (IAP)
Number of subjects: 60
Study 25112307 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (BI) involving feedback about individual risk of MOH and how to reduce overuse.
Number of subjects: 60
Study 25112307 — intervention group
Group type: COMPARATOR
Intervention: Business as usual (BAU) control group.
Number of subjects: 60
Study 24021837 — intervention group
Group type: EXPERIMENTAL
Intervention: Normalized amplitude thresholding method
Number of subjects: 0
Study 24021837 — intervention group
Group type: COMPARATOR
Intervention: Current standard thresholding methods
Number of subjects: 0
Study 22480552 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80
Study 22480552 — intervention group
Group type: COMPARATOR
Intervention: Fastrach ILMA
Number of subjects: 80
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of Eastern Cooperative Oncology Group performance status (PS) more than 0
Number of subjects: 370
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin level less than 10 g/dL
Number of subjects: 370
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of liver metastasis
Number of subjects: 370
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: Zero prognostic factors
Number of subjects: 370
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: One prognostic factor
Number of subjects: 370
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: Two prognostic factors
Number of subjects: 370
Study 20231682 — intervention group
Group type: EXPERIMENTAL
Intervention: Three prognostic factors
Number of subjects: 370
Study 17339234 — intervention group
Group type: EXPERIMENTAL
Intervention: Asoprisnil 10 mg
Number of subjects: 33
Study 17339234 — intervention group
Group type: EXPERIMENTAL
Intervention: Asoprisnil 25 mg
Number of subjects: 33
Study 17339234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 16291107 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted spinal manipulation
Number of subjects: 34
Study 16291107 — intervention group
Group type: COMPARATOR
Intervention: Unassisted spinal manipulation
Number of subjects: 34
Study 16291107 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted joint preload force
Number of subjects: 34
Study 16291107 — intervention group
Group type: COMPARATOR
Intervention: Unassisted joint preload force
Number of subjects: 34
Study 16291107 — intervention group
Group type: EXPERIMENTAL
Intervention: L5-S1 side-posture SM
Number of subjects: 34
Study 16291107 — intervention group
Group type: COMPARATOR
Intervention: Side-posture positioning maneuver
Number of subjects: 34
Study 12224691 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids with orally administered prednisone (group A)
Number of subjects: 20
Study 12224691 — intervention group
Group type: COMPARATOR
Intervention: Systemic corticosteroids alternating a pulse of intravenous betamethasone with orally administered prednisone (group B)
Number of subjects: 20
Study 10320384 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (2 g orally four times daily for 90 days)
Number of subjects: 616
Study 10320384 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir
Number of subjects: 616
Study 10320384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 616
Study 8907140 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine sulfate solution or controlled‐release morphine tablets
Number of subjects: 39
Study 8907140 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine administration
Number of subjects: 39
Study 8907140 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine plus M6G concentrations in the optimal control group
Number of subjects: 39
Study 8907140 — intervention group
Group type: EXPERIMENTAL
Intervention: morphine plus M6G plasma concentrations
Number of subjects: 39
Study 1986523 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic extrusion for 1, 2, or 4 weeks
Number of subjects: 36
Study 1986523 — intervention group
Group type: COMPARATOR
Intervention: Control group (contralateral maxillary first premolars not extruded)
Number of subjects: 36
Study 6849724 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormethiazole (mean 6.0 mg kg‐1)
Number of subjects: 16
Study 6849724 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone (mean 4.5 mg kg‐1)
Number of subjects: 16
Study 6849724 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlormethiazole
Number of subjects: 16
Study 6849724 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 16
Study 31930896 — intervention group
Group type: EXPERIMENTAL
Intervention: Bloodletting acupuncture at jing-well points combined with routine acupuncture
Number of subjects: 60
Study 31930896 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 60
Study 31393619 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (6 g/L)
Number of subjects: 0
Study 31393619 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine (12 g/L)
Number of subjects: 0
Study 31393619 — intervention group
Group type: COMPARATOR
Intervention: Control (no L-carnitine)
Number of subjects: 0
Study 30156033 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise regimen (Comb-Ex)
Number of subjects: 11
Study 30156033 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (HP diet)
Number of subjects: 11
Study 30156033 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (HP diet and Comb-Ex)
Number of subjects: 11
Study 30156033 — intervention group
Group type: COMPARATOR
Intervention: Neither group
Number of subjects: 11
Study 27610025 — intervention group
Group type: EXPERIMENTAL
Intervention: EMVI-positive patients
Number of subjects: 194
Study 27610025 — intervention group
Group type: COMPARATOR
Intervention: EMVI-negative patients
Number of subjects: 194
Study 27610025 — intervention group
Group type: EXPERIMENTAL
Intervention: ctEMVI
Number of subjects: 194
Study 24508782 — intervention group
Group type: EXPERIMENTAL
Intervention: rilpivirine/emtricitabine/tenofovir disoproxil fumarate (RPV/FTC/TDF)
Number of subjects: 786
Study 24508782 — intervention group
Group type: COMPARATOR
Intervention: efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF)
Number of subjects: 786
Study 22992012 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-inflammatory cytokines
Number of subjects: 0
Study 22992012 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory cytokines
Number of subjects: 0
Study 22992012 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokines
Number of subjects: 0
Study 19442381 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprafascial dissection with sheet graft reconstruction
Number of subjects: 62
Study 19442381 — intervention group
Group type: COMPARATOR
Intervention: Suprafascial dissection with meshed graft reconstruction
Number of subjects: 62
Study 19442381 — intervention group
Group type: COMPARATOR
Intervention: Subfascial dissection with meshed graft reconstruction
Number of subjects: 62
Study 19442381 — intervention group
Group type: COMPARATOR
Intervention: Subfascial dissection with sheet graft reconstruction
Number of subjects: 62
Study 17316098 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention plus usual care
Number of subjects: 62
Study 17316098 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 62
Study 15347711 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D stereotactic surface projection (3D-SSP) technique
Number of subjects: 38
Study 15347711 — intervention group
Group type: COMPARATOR
Intervention: Visual inspection
Number of subjects: 38
Study 11673331 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern adaptation (motion after-effect and tilt after-effect) in migraine sufferers
Number of subjects: 0
Study 11673331 — intervention group
Group type: COMPARATOR
Intervention: Headache-free control subjects
Number of subjects: 0
Study 9541124 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of [14C]-palmitate for 60 min (study A)
Number of subjects: 12
Study 9541124 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of [14C]-palmitate for 10 min (study B)
Number of subjects: 12
Study 9541124 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion of [14C]-palmitate for 60 min (study A) and 10 min (study B)
Number of subjects: 12
Study 9078536 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose (30 g)
Number of subjects: 8
Study 9078536 — intervention group
Group type: COMPARATOR
Intervention: Control (i.v. glucose infusion without oral glucose)
Number of subjects: 8
Study 2667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 40 mg
Number of subjects: 60
Study 2667597 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 80 mg
Number of subjects: 60
Study 2667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg plus Propranolol 40 mg
Number of subjects: 60
Study 2667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 20 mg plus Propranolol 40 mg
Number of subjects: 60
Study 2667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg plus Propranolol 80 mg
Number of subjects: 60
Study 2667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine monotherapy
Number of subjects: 60
Study 2667597 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol monotherapy
Number of subjects: 60
Study 3197 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalorphine
Number of subjects: 0
Study 3197 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 0
Study 3197 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0
Study 3197 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin
Number of subjects: 0
Study 3197 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 31808180 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning intervention on parenteral nutrition
Number of subjects: 65
Study 31808180 — intervention group
Group type: COMPARATOR
Intervention: Control group (no e-learning)
Number of subjects: 65
Study 31808180 — intervention group
Group type: COMPARATOR
Intervention: Iterative tests in HOSP1
Number of subjects: 65
Study 31808180 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning satisfaction
Number of subjects: 65
Study 31591676 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate
Number of subjects: 65
Study 31591676 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate with monoethyl fumarate salts
Number of subjects: 65
Study 31591676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 27292167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg/ml
Number of subjects: 68
Study 27292167 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 68
Study 26507554 — intervention group
Group type: EXPERIMENTAL
Intervention: SASA! intervention to prevent violence against women
Number of subjects: 0
Study 23277421 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist-led pharmaceutical care in addition to standard care
Number of subjects: 0
Study 23277421 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study 20947210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine/propofol
Number of subjects: 136
Study 20947210 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 136
Study 19223439 — intervention group
Group type: EXPERIMENTAL
Intervention: Secretin (RG1068; 20 microg/kg)
Number of subjects: 25
Study 19223439 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (20 microg/kg)
Number of subjects: 25
Study 16823250 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation (LFES) for 8 weeks, 1 hour/day, 7 days/week
Number of subjects: 30
Study 16823250 — intervention group
Group type: COMPARATOR
Intervention: Bicycle training for 8 weeks, 40 minutes, 3 times a week
Number of subjects: 30
Study 12919708 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of alendronate daily plus progressive jumping exercise
Number of subjects: 164
Study 12919708 — intervention group
Group type: COMPARATOR
Intervention: 5 mg alendronate
Number of subjects: 164
Study 12919708 — intervention group
Group type: COMPARATOR
Intervention: placebo plus progressive jumping exercise
Number of subjects: 164
Study 12919708 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 164
Study 10772184 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of oral glutamine daily
Number of subjects: 58
Study 10772184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 9291287 — intervention group
Group type: COMPARATOR
Intervention: Local nasal immunotherapy (LNIT) with extracts in powder, administered pre-seasonally.
Number of subjects: 0
Study 8317653 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthesia
Number of subjects: 169
Study 8317653 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia
Number of subjects: 169
Study 3823668 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaires with only factual questions
Number of subjects: 1600
Study 3823668 — intervention group
Group type: COMPARATOR
Intervention: Questionnaires sent by a government organization
Number of subjects: 1600
Study 3823668 — intervention group
Group type: COMPARATOR
Intervention: Questionnaires with precoded answers
Number of subjects: 1600
Study 30126437 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strategy practice change intervention including leadership support, local clinical practice guidelines, electronic prompts and reminders, opinion leaders, academic detailing, educational meetings, educational materials, and performance monitoring.
Number of subjects: 0
Study 30126437 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strategy practice change intervention
Number of subjects: 0
Study 26951923 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic catheter
Number of subjects: 50
Study 26951923 — intervention group
Group type: COMPARATOR
Intervention: PVC catheter
Number of subjects: 50
Study 24907632 — intervention group
Group type: EXPERIMENTAL
Intervention: One-person Simon Says tasks
Number of subjects: 74
Study 24907632 — intervention group
Group type: COMPARATOR
Intervention: Two-person Simon Says tasks
Number of subjects: 74
Study 24907632 — intervention group
Group type: COMPARATOR
Intervention: Bear-Dragon task
Number of subjects: 74
Study 24907632 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of experimenter's movements
Number of subjects: 74
Study 22049177 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein and high dairy (HPHD)
Number of subjects: 90
Study 22049177 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate protein and medium dairy (APMD)
Number of subjects: 90
Study 22049177 — intervention group
Group type: COMPARATOR
Intervention: Adequate protein and low dairy (APLD)
Number of subjects: 90
Study 20452705 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT with CPAP
Number of subjects: 50
Study 20452705 — intervention group
Group type: COMPARATOR
Intervention: SBT with T-piece
Number of subjects: 50
Study 18021826 — intervention group
Group type: EXPERIMENTAL
Intervention: Freegenol provisional cement enriched with chlorhexidine diacetate (CHDA)
Number of subjects: 12
Study 18021826 — intervention group
Group type: EXPERIMENTAL
Intervention: Temp Bond provisional cement with chlorhexidine diacetate (CHDA)
Number of subjects: 12
Study 18021826 — intervention group
Group type: EXPERIMENTAL
Intervention: Temp Bond NE provisional cement with chlorhexidine diacetate (CHDA)
Number of subjects: 12
Study 18021826 — intervention group
Group type: COMPARATOR
Intervention: Control group (no luting agent)
Number of subjects: 12
Study 18021826 — intervention group
Group type: EXPERIMENTAL
Intervention: All tested cements with chlorhexidine diacetate (CHDA)
Number of subjects: 12
Study 16095478 — intervention group
Group type: EXPERIMENTAL
Intervention: Five treatments for neurotic disorders (specific treatments not detailed)
Number of subjects: 210
Study 12444376 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic injection therapy with 1% aethoxysclerol, intravenous 40 mg omeprazole twice a day, and somatostatin infusion at the dose of 6 mg/day during 3 days (group-1)
Number of subjects: 52
Study 12444376 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment with the same agents and doses without perendoscopic therapy (group-2)
Number of subjects: 52
Study 12444376 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic injection therapy with 1% aethoxysclerol (group-1)
Number of subjects: 52
Study 12444376 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment without perendoscopic therapy (group-2)
Number of subjects: 52
Study 10090348 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine CC (10 mg to 40 mg daily)
Number of subjects: 96
Study 10090348 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10 mg to 40 mg daily)
Number of subjects: 96
Study 7598297 — intervention group
Group type: EXPERIMENTAL
Intervention: No routine ventilator circuit changes
Number of subjects: 300
Study 7598297 — intervention group
Group type: COMPARATOR
Intervention: Circuit changes every 7 days
Number of subjects: 300
Study 2240672 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.75 mg.kg-1 po and atropine 0.03 mg.kg-1 po
Number of subjects: 124
Study 2240672 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 0.50 mg.kg-1 po and atropine 0.03 mg.kg-1 po
Number of subjects: 124
Study 2240672 — intervention group
Group type: COMPARATOR
Intervention: Placebo (containing the midazolam vehicle, atropine, and apple juice)
Number of subjects: 124